ACADIA Pharmaceuticals (DR6) Q2 2024 Earnings Report
DE:DR6 Q2 2024 EPS Results
- Actual EPS
- EUR 0.18
- Consensus EPS
- EUR 0.16
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- EUR 0.01
DE:DR6 Q2 2024 Revenue Results
- Actual Revenue
- EUR 215.93M
- Expected Revenue
- EUR 210.56M
- Beat/Miss
- Beat by +EUR 5.37M
- YoY Revenue Growth
- +46.44%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- After Close
- Conference Call
- Tuesday, August 6, 2024
DE:DR6 Upcoming Earnings
ACADIA Pharmaceuticals's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:DR6 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:DR6 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 0.18- | 0.37 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | 0.060.16 | 0.14 | 12.50% (+0.02) | |
| May 06, 2026 | 2026 (Q1) | 0.050.02 | 0.1 | -81.82% (-0.08) | |
| Feb 25, 2026 | 2025 (Q4) | 0.121.43 | 0.77 | 86.05% (+0.66) | |
| Nov 05, 2025 | 2025 (Q3) | 0.150.37 | 0.18 | 110.00% (+0.20) | |
| Aug 06, 2025 | 2025 (Q2) | 0.120.14 | 0.18 | -20.00% (-0.04) | |
| May 07, 2025 | 2025 (Q1) | 0.080.10 | 0.09 | 10.00% (+0.01) | |
| Feb 26, 2025 | 2024 (Q4) | 0.190.77 | 0.25 | 207.14% (+0.52) | |
| Nov 06, 2024 | 2024 (Q3) | 0.120.18 | -0.36 | 150.00% (+0.54) | |
| Aug 06, 2024 | 2024 (Q2) | 0.160.18 | 0.01 | 1900.00% (+0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed